Stock Earnings

Question 1

Quels sont les états financiers clés de Sihuan Pharmaceutical Holdings Group Ltd ?

Accepted Answer

Selon le dernier état financier (Form-10K), Sihuan Pharmaceutical Holdings Group Ltd a un total d'actifs de $10,531, un bénéfice net loss de $-216

Question 2

Quels sont les ratios financiers clés pour SHPHY ?

Accepted Answer

Le ratio de liquidité de Sihuan Pharmaceutical Holdings Group Ltd est 1.7, la marge nette est -11.36, les ventes par action sont de $0.2.

Question 3

Comment les revenus de Sihuan Pharmaceutical Holdings Group Ltd sont-ils répartis par segment ou géographie ?

Accepted Answer

Sihuan Pharmaceutical Holdings Group Ltd largest revenue segment is Generic Medicine, at a revenue of 1,191,874,310 in the most earnings release.For geography, China is the primary market for Sihuan Pharmaceutical Holdings Group Ltd, at a revenue of 2,047,607,773.

Question 4

Sihuan Pharmaceutical Holdings Group Ltd est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Sihuan Pharmaceutical Holdings Group Ltd a un bénéfice net loss de $-216

Question 5

Sihuan Pharmaceutical Holdings Group Ltd a-t-elle des passifs ?

Accepted Answer

yes, Sihuan Pharmaceutical Holdings Group Ltd a un passif de 6,159

Question 6

Combien d'actions en circulation Sihuan Pharmaceutical Holdings Group Ltd a-t-elle ?

Accepted Answer

Sihuan Pharmaceutical Holdings Group Ltd a un total d'actions en circulation de 9,244.06

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,097	1,901	1,860	2,181	3,038	2,464
Revenue Growth (YoY)	20%	2%	-15%	-28%	23%	-14%
Cost of Revenue	707	659	564	693	607	549
Gross Profit	1,390	1,241	1,295	1,487	2,430	1,914
Selling, General & Admin	1,165	1,175	911	1,023	1,128	858
Research & Development	431	473	577	936	868	729
Operating Expenses	1,544	1,631	1,436	2,023	1,754	1,428
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-252	-428	-161	-2,122	496	765
Income Tax Expense	85	43	96	196	253	219
Net Income	-80	-216	-54	-1,914	416	473
Net Income Growth	115.99%	300%	-97%	-560%	-12%	-117%
Shares Outstanding (Diluted)	9,204.01	9,265.98	9,297.07	9,329.99	9,483.38	9,465.68
Shares Change (YoY)	-1%	0%	0%	-2%	0%	0%
EPS (Diluted)	0	-0.02	0	-0.2	0.04	0.05
EPS Growth	112%	303%	-97%	-565%	-16%	-119%
Free Cash Flow	-71	57	-95	-547	-60	-353
Free Cash Flow Per Share	0	0	-0.01	-0.05	0	-0.03
Gross Margin	66.28%	65.28%	69.62%	68.17%	79.98%	77.67%
Operating Margin	-7.34%	-20.46%	-7.52%	-24.57%	22.25%	19.68%
Profit Margin	-3.81%	-11.36%	-2.9%	-87.75%	13.69%	19.19%
Free Cash Flow Margin	-3.38%	2.99%	-5.1%	-25.08%	-1.97%	-14.32%
EBITDA	78	-143	76	-175	977	755
EBITDA Margin	3.71%	-7.52%	4.08%	-8.02%	32.15%	30.64%
D&A For EBITDA	232	246	216	361	301	270
EBIT	-154	-389	-140	-536	676	485
EBIT Margin	-7.34%	-20.46%	-7.52%	-24.57%	22.25%	19.68%
Effective Tax Rate	-33.73%	-10.04%	-59.62%	-9.23%	51%	28.62%

Sihuan Pharmaceutical Holdings Group Ltd (SHPHY) Price

SHPHY Stock Price Chart

SHPHY Income

Follow-Up Questions